HANNA KIM: Open Payments
NPI 1215645098 · LAKEWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 55 payments from 15 companies in 2025. Trend: 2023 $164 · 2024 $984 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $270 |
| Phathom Pharmaceuticals, Inc. | 8 | $268 |
| AstraZeneca Pharmaceuticals LP | 6 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Abbott Laboratories | 2 | $38 |
| Novo Nordisk Inc | 2 | $34 |
| Dexcom, Inc. | 1 | $30 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: VOQUEZNA, LINZESS, JARDIANCE, FARXIGA, BREZTRI, GEMTESA, AIRSUPRA, FREESTYLE LIBRE 3.
Industry payments across WA — which companies pay providers there.
